CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 4 Gift CEO and President gave 2,000 shares (gift)
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 8-K Event Regulation FD disclosure
- 4 Open-market sale SVP-Chief Financial Officer sold 3,000 shares at $8.00 ($24,000)
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 94 shares (to pay taxes)
- 4 Shares withheld for taxes CEO and President gave up 148 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 24 of 35 · 690 filings